GlobeNewswire 19/11/2019 Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Le...
GlobeNewswire 06/11/2019 Genmab Announces Financial Results for the First Nine Months of 2019
GlobeNewswire 30/10/2019 David Eatwell to Retire as Chief Financial Officer of Genmab
GlobeNewswire 18/10/2019 CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Lenalidomide a...
GlobeNewswire 15/10/2019 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2019
GlobeNewswire 26/09/2019 Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Bortezomib, Thalid...
GlobeNewswire 13/09/2019 Genmab Announces Positive Topline Results in Phase III Study of Daratumumab in Combination with Carf...
GlobeNewswire 13/09/2019 Detailed Results from the Phase III ASCLEPIOS I & II Studies of Ofatumumab in Patients with Relapsin...
GlobeNewswire 09/09/2019 Genmab and Tempus Enter into Strategic Collaboration Agreement
GlobeNewswire 30/08/2019 Ofatumumab Demonstrates Superiority Versus Teriflunomide in Two Head-to-Head Phase III Multiple Scle...
GlobeNewswire 22/08/2019 Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan
GlobeNewswire 14/08/2019 Genmab Announces Financial Results for the First Half of 2019 and Updates 2019 Financial Guidance
GlobeNewswire 23/07/2019 Genmab Announces the Closing of Over-Allotment Option in Initial Public Offering of American Deposit...
GlobeNewswire 22/07/2019 Genmab Announces the Completion of its Initial Public Offering of American Depositary Shares (ADSs) ...
GlobeNewswire 19/07/2019 Major Shareholder Announcement
GlobeNewswire 19/07/2019 Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering
GlobeNewswire 18/07/2019 Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States
GlobeNewswire 16/07/2019 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2019
GlobeNewswire 12/07/2019 Genmab Announces Submission of Biologics License Application to U.S. FDA for Subcutaneous Formulatio...
GlobeNewswire 09/07/2019 Genmab Commences Public Offering of American Depositary Shares (ADSs) in the United States
GlobeNewswire 08/07/2019 Genmab Announces Positive Topline Results in the Phase II GRIFFIN Study of Transplant Eligible, Newl...
GlobeNewswire 27/06/2019 Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Lenalidomide and D...
GlobeNewswire 25/06/2019 Major Shareholder Announcement
GlobeNewswire 19/06/2019 Major Shareholder Announcement
GlobeNewswire 19/06/2019 Major Shareholder Announcement